ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
정밀 종양학 시장 규모는 최근 급성장하고 있습니다. 2025년 1,062억 1,000만 달러에서 2026년에는 1,176억 7,000만 달러에 이르고, CAGR 10.8%의 성장이 전망되고 있습니다. 지난 몇 년간 성장 요인으로는 제한적인 유전체 시퀀싱 기술의 보급, 기존 화학요법에 대한 의존도, 전 세계 암 발병률 증가, 면역치료의 조기 도입, 분자종양학 분야의 연구 진전 등을 꼽을 수 있습니다.
정밀 종양학 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 1,753억 8,000만 달러에 이르고, CAGR은 10.5%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 차세대 시퀀싱 플랫폼의 개발, 종양학 분야에서의 생물정보학 및 AI의 통합 확대, 액체 생검 및 분자 이미징의 채택 증가, 개인 맞춤형 치료 옵션의 확대, 병원과 제약사 간의 연구 협력의 진전 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 분자 프로파일링에 기반한 표적 암 치료의 확대, 액체 생검 및 비침습적 진단 방법의 채택 증가, 개인 맞춤형 치료 계획을 위한 바이오마커 검사의 성장, 면역 치료와 유전체 시퀀싱의 통합 발전, 희귀암 및 난치성 암종에 대한 관심 증가 등이 있습니다.
맞춤치료에 대한 인식 증가와 전환이 향후 정밀종양학 시장의 성장을 가속할 것으로 예측됩니다. 개인맞춤치료는 환자의 유전자 정보, 마커, 질병 특성에 맞추어 치료함으로써 보다 높은 효과와 부작용을 줄일 수 있습니다. 이러한 성장은 돌연변이 유발 요인을 정확히 찾아내어 표적 치료를 가능하게 하는 유전체 기술의 발전에 힘입은 바 큽니다. 정밀 종양학은 종양 유전체 및 분자 스캔을 통해 개인별 맞춤 치료를 추진하고, 암 치료를 개인 프로파일에 맞게 맞춤화합니다. 예를 들어, 2023년 2월 영국 정부(GOV.UK)는 보건사회부 장관과 BioNTech SE와의 양해각서를 발표하여 영국에서 암 백신 연구를 추진했습니다. 2030년까지 영국 환자들에게 1만 회 분량의 개인 맞춤형 백신을 공급하는 것을 목표로 하고 있습니다. 이처럼 개인 맞춤형 치료에 대한 인식 증가와 전환이 정밀 종양학 시장을 주도하고 있습니다.
정밀 종양학 시장의 주요 기업들은 분자 종양 보드와 같은 선구적인 방법을 추진하고 있으며, 유전체 데이터와 임상적 지식을 융합하여 개인 맞춤형 치료 의사결정을 지원하고 있습니다. 분자종양위원회는 복잡한 유전체-분자 검사 결과를 면밀히 검토하고, 종양의 특성에 따라 환자별 치료 계획을 수립하는 전문가 팀입니다. 예를 들어, 2024년 12월 아랍에미리트의 헬스케어 네트워크인 Astor DM Healthcare는 데이터 기반 유전자 중심 전략을 활용한 3개의 맞춤형 암 프로그램을 갖춘 정밀 종양학 클리닉을 개소했습니다. 이 클리닉은 종양의 유전자 정보로부터 개인별 맞춤 치료를 구축하여 높은 정확도, 좋은 치료 결과, 부작용 감소를 실현하고 있습니다. 이를 통해 치료법이 암 분자 자체에 맞춤화되어 생존율 향상, 부작용 억제, 삶의 질 향상으로 이어지고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Precision oncology is a medical approach that customizes cancer treatment based on the unique characteristics of each patient. This strategy utilizes molecular and genetic profiling of tumors to identify specific mutations, biomarkers, or pathways driving cancer progression, enabling clinicians to choose targeted therapies that are more effective and less toxic compared with conventional treatments.
The main types of precision oncology include genomic sequencing and immunotherapy. Genomic sequencing involves determining the complete DNA sequence of an organism's genome at a given time. Product offerings in this area include genetic tests, biomarker-based tests, and targeted therapeutics, applied in treating various cancers such as breast, lung, colorectal, prostate, skin, stomach, and others. Supporting technologies include next-generation sequencing, bioinformatics, molecular imaging, and liquid biopsy. The primary end users are hospitals, research laboratories, pharmaceutical companies, and diagnostic centers.
Tariffs have impacted the precision oncology market by increasing costs of imported sequencing equipment, reagents, and biologic therapeutics. Segments such as genomic sequencing platforms, biomarker-based tests, and immunotherapy products are most affected, with North America, Europe, and Asia-Pacific regions reliant on imports facing higher operational costs. While tariffs have slowed supply chains and raised treatment costs, they have also encouraged local production, investment in domestic research infrastructure, and innovation in cost-effective precision oncology solutions.
The precision oncology market research report is one of a series of new reports from The Business Research Company that provides precision oncology market statistics, including precision oncology industry global market size, regional shares, competitors with a precision oncology market share, detailed precision oncology market segments, market trends and opportunities, and any further data you may need to thrive in the precision oncology industry. This precision oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The precision oncology market size has grown rapidly in recent years. It will grow from $106.21 billion in 2025 to $117.67 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to limited availability of genomic sequencing technologies, reliance on conventional chemotherapy, increasing cancer prevalence globally, early adoption of immunotherapy, growing research in molecular oncology.
The precision oncology market size is expected to see rapid growth in the next few years. It will grow to $175.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to development of next-generation sequencing platforms, increasing integration of bioinformatics and AI in oncology, rising adoption of liquid biopsy and molecular imaging, expansion of personalized treatment options, growth of research collaborations between hospitals and pharmaceutical companies. Major trends in the forecast period include expansion of targeted cancer therapies based on molecular profiling, increasing adoption of liquid biopsy and non-invasive diagnostic methods, growth in biomarker-based testing for personalized treatment plans, rising integration of immunotherapy with genomic sequencing, enhanced focus on rare and hard-to-treat cancer types.
The heightened recognition and pivot to personalized therapies is set to boost the precision oncology market ahead. Personalized therapies adapt to a patient's genetics, markers, and disease traits for sharper efficacy and fewer downsides. Their growth flows from genomic tech strides that spot mutation drivers precisely, unlocking targeted fixes. Precision oncology propels personalized therapies via tumor genomic and molecular scans to customize cancer care to individual profiles. For example, in February 2023, GOV.UK announced the Health and Social Care Secretary's MoU with BioNTech SE to push cancer vaccine work in England, targeting 10,000 personalized doses for UK patients by 2030. Thus, the rising awareness and shift to personalized therapies is fueling the precision oncology market.
Top companies in the precision oncology market are pioneering methods like molecular tumor boards to guide bespoke decisions by blending genomic data with clinical insights. A molecular tumor board is an expert team reviewing intricate genomic and molecular results to shape patient-specific cancer plans based on tumor specifics. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE healthcare network, launched a precision oncology clinic within three tailored cancer programs, harnessing data-led, gene-centric tactics. It crafts individualized therapies from tumor genetics, yielding pinpoint accuracy, better results, and slimmer side effects. This aligns treatments to unique cancer molecules, lifting survival, curbing harm, and enriching life quality.
In March 2024, Bayer AG, a Germany-based pharma leader, allied with Aignostics GmbH to elevate precision oncology using the latter's AI pathology and patient data for smarter cancer drug hunts. Aignostics GmbH is a Germany AI firm supplying tools honed for precision oncology.
Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.
North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the precision oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The precision oncology market consists of revenues earned by entities by providing services such as genomic and molecular profiling services, companion diagnostics services, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision oncology market also includes sales of genomic and molecular diagnostic equipment, immune checkpoint inhibitors, and bioinformatics and decision support tools. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Precision Oncology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses precision oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for precision oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision oncology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Genomic Sequencing; Immunotherapy
2) By Test Type: Genetic Tests; Biomarker-Based Tests; Therapeutics
3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Skin Cancer; Stomach Cancer; Other Cancers
4) By Technology: Next-Generation Sequencing; Bioinformatics; Molecular Imaging; Liquid Biopsy
5) By End-users: Hospitals; Research Laboratories; Pharmaceutical Companies; Diagnostic Centers
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Expansion Of Targeted Cancer Therapies Based On Molecular Profiling
4.2.2 Increasing Adoption Of Liquid Biopsy And Non-Invasive Diagnostic Methods
4.2.3 Growth In Biomarker-Based Testing For Personalized Treatment Plans
4.2.4 Rising Integration Of Immunotherapy With Genomic Sequencing
4.2.5 Enhanced Focus On Rare And Hard-To-Treat Cancer Types
5. Precision Oncology Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Research Laboratories
5.3 Pharmaceutical Companies
5.4 Diagnostic Centers
5.5 Oncology Specialty Clinics
6. Precision Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Precision Oncology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Precision Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Precision Oncology Market Size, Comparisons And Growth Rate Analysis
7.3. Global Precision Oncology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Precision Oncology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Precision Oncology Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Precision Oncology Market Segmentation
9.1. Global Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Genomic Sequencing, Immunotherapy
9.2. Global Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Precision Oncology Market
12.1. China Precision Oncology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Precision Oncology Market
13.1. India Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Precision Oncology Market
14.1. Japan Precision Oncology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Precision Oncology Market
15.1. Australia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Precision Oncology Market
16.1. Indonesia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Precision Oncology Market
17.1. South Korea Precision Oncology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Precision Oncology Market
18.1. Taiwan Precision Oncology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Precision Oncology Market
19.1. South East Asia Precision Oncology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Precision Oncology Market
20.1. Western Europe Precision Oncology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Precision Oncology Market
21.1. UK Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Precision Oncology Market
22.1. Germany Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Precision Oncology Market
23.1. France Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Precision Oncology Market
24.1. Italy Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Precision Oncology Market
25.1. Spain Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Precision Oncology Market
26.1. Eastern Europe Precision Oncology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Precision Oncology Market
27.1. Russia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Precision Oncology Market
28.1. North America Precision Oncology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Precision Oncology Market
29.1. USA Precision Oncology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Precision Oncology Market
30.1. Canada Precision Oncology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Precision Oncology Market
31.1. South America Precision Oncology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Precision Oncology Market
32.1. Brazil Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Precision Oncology Market
33.1. Middle East Precision Oncology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Precision Oncology Market
34.1. Africa Precision Oncology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Precision Oncology Market Regulatory and Investment Landscape
36. Precision Oncology Market Competitive Landscape And Company Profiles
36.1. Precision Oncology Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Precision Oncology Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Precision Oncology Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
37. Precision Oncology Market Other Major And Innovative Companies
Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.
38. Global Precision Oncology Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Precision Oncology Market
40. Precision Oncology Market High Potential Countries, Segments and Strategies
40.1 Precision Oncology Market In 2030 - Countries Offering Most New Opportunities
40.2 Precision Oncology Market In 2030 - Segments Offering Most New Opportunities
40.3 Precision Oncology Market In 2030 - Growth Strategies
